Varian's Trilogy products:
This article was originally published in Clinica
Varian Medical Systems has gained US FDA 510(k) market clearance to use its high-energy, "ultra-precise" Trilogy linear accelerators on an expanded range of medical conditions. The clearance also marks the introduction of Varian's new Trilogy Tx image-guided radiosurgery (IGRS) model, designed specifically for surgeons. Physicians can now provide Trilogy treatments for functional lesions such as trigeminal neuralgia and other non-cancerous conditions, said the Palo Alto, California firm. The prior FDA clearance for the Trilogy device was limited to benign and malignant cancers, and arteriovenous malformations.